Persistent Changes of Peripheral Blood Lymphocyte Subsets in Patients with Oral Squamous Cell Carcinoma
- PMID: 35206956
- PMCID: PMC8872623
- DOI: 10.3390/healthcare10020342
Persistent Changes of Peripheral Blood Lymphocyte Subsets in Patients with Oral Squamous Cell Carcinoma
Abstract
Background: Oral squamous cell carcinoma (OSCC) is a common cancer with high morbidity and mortality. Alterations of antitumor immune responses are involved in the development of this malignancy, and investigation of immune changes in the peripheral blood of OSCC patients has aroused the interest of researchers.
Methods: In our study, we assessed the proportions of CD3+ total T lymphocytes, CD3+CD4+ helper T lymphocytes, CD3+CD8+ suppressor/cytotoxic T lymphocytes, CD3-CD19+ total B lymphocytes, and CD3-CD16+CD56+ NK cells in the peripheral blood of OSCC patients.
Results: The data obtained both pre- and post-therapy showed a similar level of total CD3+ T lymphocytes in OSCC patients and control subjects, pinpointing the stability of this immune parameter. On the other hand, pre-therapeutic data showed a lower proportion of helper T lymphocytes (CD4+), a significantly higher level of cytotoxic/suppressive T lymphocytes (CD8+), and a much lower CD4+ T lymphocyte/CD8+ T lymphocyte ratio compared to control subjects. Conversely, evaluation of circulating NK (CD16+) cells showed a markedly higher pre-therapeutic level compared to the control group.
Conclusions: Our results related to immune changes in the peripheral blood add new information to this complex universe of connections between immuno-inflammatory processes and carcinogenesis.
Keywords: flow cytometry; head and neck cancer; lymphocyte subpopulations; peripheral circulation; squamous cell carcinoma.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Similar articles
-
Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy.Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211039948. doi: 10.1177/15330338211039948. Technol Cancer Res Treat. 2021. PMID: 34851203 Free PMC article.
-
Comparison of the composition of lymphocyte subpopulations in non-relapse and relapse patients with squamous cell carcinoma of the head and neck before, during radiochemotherapy and in the follow-up period: a multicenter prospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).Radiat Oncol. 2021 Jul 31;16(1):141. doi: 10.1186/s13014-021-01868-5. Radiat Oncol. 2021. PMID: 34332614 Free PMC article.
-
Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue.Tumour Biol. 2016 Mar;37(3):3807-16. doi: 10.1007/s13277-015-4224-2. Epub 2015 Oct 16. Tumour Biol. 2016. PMID: 26474587
-
Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1345-55. doi: 10.1016/s0360-3016(02)03757-4. Int J Radiat Oncol Biol Phys. 2002. PMID: 12459356
-
[Deep lung--cellular reaction to HIV].Rev Port Pneumol. 2007 Mar-Apr;13(2):175-212. Rev Port Pneumol. 2007. PMID: 17492233 Review. Portuguese.
Cited by
-
Role of Cannabinoids in Oral Cancer.Int J Mol Sci. 2024 Jan 12;25(2):969. doi: 10.3390/ijms25020969. Int J Mol Sci. 2024. PMID: 38256042 Free PMC article. Review.
-
4-nitroquinoline 1-oxide induces immune cells death to onset early immunosuppression during oral squamous cell carcinoma development.Front Immunol. 2023 Oct 23;14:1274519. doi: 10.3389/fimmu.2023.1274519. eCollection 2023. Front Immunol. 2023. PMID: 37936711 Free PMC article.
-
Editorial: Recent advances in keratinocyte carcinomas: From molecular mechanisms to clinical perspectives.Front Med (Lausanne). 2022 Nov 3;9:1078020. doi: 10.3389/fmed.2022.1078020. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36405605 Free PMC article. No abstract available.
-
The Assessment of Serum Cytokines in Oral Squamous Cell Carcinoma Patients: An Observational Prospective Controlled Study.J Clin Med. 2022 Sep 14;11(18):5398. doi: 10.3390/jcm11185398. J Clin Med. 2022. PMID: 36143043 Free PMC article.
-
Assessment of Serum Urea, Creatinine and Uric Acid in Oral Cancer.J Clin Med. 2022 Jun 16;11(12):3459. doi: 10.3390/jcm11123459. J Clin Med. 2022. PMID: 35743528 Free PMC article.
References
-
- Economopoulou P., Psyrri A. Epidemiology, Risk Factors and Pathogenesis of Squamous Cell Tumours. In: Licitra L., Karamouzis M.V., editors. Head and Neck Cancer: Essentials for Clinicians. 6th ed. ESMO; Lugano, Switzerland: 2017. pp. 1–6.
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
